1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Protagonist Therapeutics Inc (PTGX)
  7. News

PTGX

Protagonist Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.43 1.32% 33.00 16:53:35
Open Price Low Price High Price Close Price Prev Close
32.26 31.0601 33.77 33.62 32.57
more quote information »

Recent News

Date Time Source Heading
11/30/202112:32IHNWFeaturedDEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT
11/30/202110:07IHNWFeaturedCybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress
11/15/202108:00SEEKPhase 2a data supports Protagonist genetic liver disease..
11/15/202107:00PRNUSProtagonist Therapeutics Announces Positive Phase 2a Data..
11/11/202107:00PRNUSProtagonist Therapeutics to Participate in Two Upcoming..
11/04/202107:00PRNUSProtagonist Therapeutics Announces Updated Data from Phase 2..
11/03/202117:28SEEKProtagonist EPS misses by $0.02, beats on revenue
11/03/202117:11EDGARQuarterly Report (10-q)
11/03/202116:05PRNUSProtagonist Therapeutics Reports Third Quarter 2021..
10/26/202107:00PRNUSProtagonist Therapeutics Earns $7.5 Million Milestone..
10/13/202120:25TRMNJ.P. Morgan: Time to Turn Bullish on These 2 Stocks
10/12/202120:31TRMNProtagonist Therapeutics: How Much More Upside is Left?
10/12/202107:00PRNUSProtagonist Therapeutics to Present at the Jefferies Next..
10/11/202112:39SEEKAPRN, CEI and GOTU among mid-day movers
10/11/202107:52DJNProtagonist Therapeutics' Clinical Hold on Rusfertide Lifted
10/11/202107:00PRNUSProtagonist Therapeutics Announces Removal of FDA Clinical..
10/04/202107:00PRNUSProtagonist Therapeutics Announces Data from Phase 2..
9/21/202116:35EDGARStatement of Ownership (sc 13g)
9/17/202117:30EDGARCurrent Report Filing (8-k)
9/17/202110:48DJNProtagonist Therapeutics Shares Tumble as FDA Puts..
9/17/202108:14SEEKIronNet, Protagonist Therapeutics among premarket losers'..
9/17/202107:51DJNProtagonist Drug Studies Placed on FDA Hold
9/17/202107:00PRNUSProtagonist Therapeutics Reports FDA Clinical Hold on..
9/15/202117:05PRNUSProtagonist Therapeutics Reports Granting of Inducement..
9/07/202107:00PRNUSProtagonist Therapeutics Appoints Scott Plevy, M.D.,..
8/19/202117:49EDGARStatement of Changes in Beneficial Ownership (4)
8/10/202108:05PRNUSProtagonist Therapeutics Announces Resolution of Contract..
8/10/202108:01EDGARCurrent Report Filing (8-k)
8/04/202116:14EDGARCurrent Report Filing (8-k)
8/04/202116:05PRNUSProtagonist Therapeutics Reports Second Quarter 2021..
7/28/202116:11EDGARCurrent Report Filing (8-k)
7/28/202116:05PRNUSProtagonist Therapeutics Announces Amendment of Agreement..
6/30/202116:27PRNUSProtagonist Therapeutics Reports Granting of Inducement..
6/18/202116:13SEEKProtagonist Therapeutics closes $132M capital raise
6/18/202116:05PRNUSProtagonist Therapeutics, Inc. Announces Closing of $132.2..
6/17/202116:59EDGARCurrent Report Filing (8-k)
6/17/202116:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/15/202123:44SEEKProtagonist Therapeutics secures $115M capital via equity..
6/15/202121:07PRNUSProtagonist Therapeutics Announces Pricing of $115 Million..
6/14/202117:28SEEKProtagonist Therapeutics slumps 7.5% on raising $100M via..
6/14/202117:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/14/202117:00PRNUSProtagonist Therapeutics Announces Proposed Public Offering..
6/14/202116:53EDGARCurrent Report Filing (8-k)
6/11/202110:59SEEKProtagonist climbs on positive effect in mid-stage study for..
6/11/202107:00PRNUSProtagonist Therapeutics Announces Updated Phase 2 Data..
6/07/202107:06PRNUSProtagonist Therapeutics to Host Investor Conference Call..
6/03/202107:00PRNUSProtagonist Therapeutics Receives FDA Breakthrough Therapy..
5/28/202119:07EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202119:02EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202119:01EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202118:50EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202118:44EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
PTGX
Protagonis..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.